To join this case, fill out the form below
By clicking on the Submit button below, I acknowledge that I have read the Retainer Agreement and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
By clicking on the Submit button below, I acknowledge that I have read the Derivative Retention Letter and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
A signed Retainer Agreement will be sent to your email shortly.
Oops! Something went wrong while submitting the form.

Physicians Realty Trust Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Physicians Realty Trust (“Physicians Realty” or the “Company”) (NYSE: DOC) in connection with its proposed merger with Healthpeak Properties, Inc. (“Healthpeak”) (NYSE: PEAK).  Under the terms of the merger agreement, the Company’s shareholders will receive 0.674 shares of Healthpeak common stock for each share of Physicians Realty common stock owned, representing implied per-share consideration of $11.07 based upon Healthpeak’s October 27, 2023 closing price of $16.42.  Pro forma for the transaction, Healthpeak and Physicians Realty Trust shareholders will own approximately 77% and 23% of the combined company, respectively.  The transaction is valued at approximately $21 billion.

Weiss Law is investigating whether (i) Physicians Realty’s board acted in the best interests of Company shareholders in agreeing to the merger, (ii) the merger consideration adequately compensates Physicians Realty’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

Other Cases